Novo Nordisk’s blockbuster diabetes drug is set to reshape India’s pharma market as the semaglutide patent expiry approaches. More than 50 companies are preparing generic versions, triggering a major race in the obesity and diabetes drug segment.
Gland Pharma receives USFDA tentative approval for Brimonidine Tartrate Ophthalmic Solution, 0.025%, expanding its ophthalmic portfolio and strengthening its US market presence.
India’s pharmaceutical industry may face export disruptions worth up to Rs 5,000 crore as escalating conflict in West Asia affects shipping routes, raises freight costs, and threatens supply chains for medicines and raw materials.
.png "India Proposes Biomanufacturing Working Group With Delaware")
India is stepping up its biomanufacturing ambitions by proposing a new working group with Delaware to boost collaboration in research, startups, and advanced biologics manufacturing.
Aurobindo Pharma’s subsidiary, Eugia Pharma, has launched Pomalidomide Capsules in the U.S., targeting the $3.3?billion oncology and specialty drug market.
A new study shows laser treatment before immunotherapy could help patients with aggressive brain tumors live longer.
Glenmark plans to launch affordable semaglutide in India, competing with major players like Sun Pharma and Dr. Reddy’s. Aiming to revolutionize the anti-diabetes market.
U.S. drugmaker Eli Lilly will continue selling its innovator diabetes and obesity drug at premium prices in India even as the market prepares for the arrival of lower-priced generic drugs. The company says it is not planning price reduction...
.jpeg "NATCO Pharma Introduces Generic Blood Cancer Drug in US Market")
NATCO Pharma launches generic Pomalidomide capsules in the US for blood and bone marrow cancer, strengthening its oncology portfolio and improving patient access to treatment.
The Medicity has launched a public awareness campaign to shift the focus from seasonal concern over air pollution to continuous monitoring and prevention of chronic respiratory diseases (CRDs).
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")